WO2003024972A1 - New oripavine derivatives and their uses as medicines - Google Patents

New oripavine derivatives and their uses as medicines Download PDF

Info

Publication number
WO2003024972A1
WO2003024972A1 PCT/CN2002/000642 CN0200642W WO03024972A1 WO 2003024972 A1 WO2003024972 A1 WO 2003024972A1 CN 0200642 W CN0200642 W CN 0200642W WO 03024972 A1 WO03024972 A1 WO 03024972A1
Authority
WO
WIPO (PCT)
Prior art keywords
methyl
medicines
new
oripavine derivatives
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2002/000642
Other languages
English (en)
French (fr)
Chinese (zh)
Other versions
WO2003024972A8 (en
Inventor
Bohua Zhong
Zehui Gong
Yaping Wang
Yongshao Liu
Boyi Qin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Pharmacology and Toxicology of AMMS
Original Assignee
Institute of Pharmacology and Toxicology of AMMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Pharmacology and Toxicology of AMMS filed Critical Institute of Pharmacology and Toxicology of AMMS
Priority to DE60225827T priority Critical patent/DE60225827D1/de
Priority to JP2003528819A priority patent/JP4532109B2/ja
Priority to US10/489,656 priority patent/US7119100B2/en
Priority to MXPA04002422A priority patent/MXPA04002422A/es
Priority to EP02764501A priority patent/EP1439179B1/en
Publication of WO2003024972A1 publication Critical patent/WO2003024972A1/zh
Anticipated expiration legal-status Critical
Priority to ZA2004/02733A priority patent/ZA200402733B/en
Publication of WO2003024972A8 publication Critical patent/WO2003024972A8/zh
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PCT/CN2002/000642 2001-09-14 2002-09-13 New oripavine derivatives and their uses as medicines Ceased WO2003024972A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE60225827T DE60225827D1 (de) 2001-09-14 2002-09-13 Neue oripavinderivate und deren verwendungen als arzneimittel
JP2003528819A JP4532109B2 (ja) 2001-09-14 2002-09-13 新規オリパビン誘導体および医薬としてのその使用
US10/489,656 US7119100B2 (en) 2001-09-14 2002-09-13 Oripavine derivatives and their uses as pharmaceuticals
MXPA04002422A MXPA04002422A (es) 2001-09-14 2002-09-13 Nuevos derivados de oripavina y su uso como farmaceuticos.
EP02764501A EP1439179B1 (en) 2001-09-14 2002-09-13 New oripavine derivatives and their uses as medicines
ZA2004/02733A ZA200402733B (en) 2001-09-14 2004-04-07 New oripavine derivatives and their uses as medicines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB011421495A CN1233645C (zh) 2001-09-14 2001-09-14 新的东罂粟碱衍生物及其医药用途
CN01142149.5 2001-09-14

Publications (2)

Publication Number Publication Date
WO2003024972A1 true WO2003024972A1 (en) 2003-03-27
WO2003024972A8 WO2003024972A8 (en) 2004-06-17

Family

ID=4676657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2002/000642 Ceased WO2003024972A1 (en) 2001-09-14 2002-09-13 New oripavine derivatives and their uses as medicines

Country Status (8)

Country Link
EP (1) EP1439179B1 (enExample)
JP (1) JP4532109B2 (enExample)
CN (1) CN1233645C (enExample)
AT (1) ATE390428T1 (enExample)
DE (1) DE60225827D1 (enExample)
MX (1) MXPA04002422A (enExample)
WO (1) WO2003024972A1 (enExample)
ZA (1) ZA200402733B (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8232397B2 (en) 2008-09-30 2012-07-31 Mallinckrodt Llc Processes for the production of buprenorphine with reduced impurity formation
US8269006B2 (en) 2008-09-30 2012-09-18 Mallinckrodt Llc Processes for the selective amination of ketomorphinans
US8273887B2 (en) 2008-09-30 2012-09-25 Mallinckrodt Llc Processes for synthesis of opiate alkaloid derivatives
EP3023427A1 (en) 2014-11-19 2016-05-25 Siegfried AG Improved method of manufacturing buprenorphine and analogues thereof from oripavine
EP3067357A1 (en) 2015-03-11 2016-09-14 Siegfried AG Method of manufacturing stereoisomers of buprenorphine and analogues thereof
US11467076B2 (en) 2016-05-19 2022-10-11 Chapelglade Limited Mattress evaluation system and method
EP4613751A1 (en) 2024-03-07 2025-09-10 Siegfried AG Method of making chemical compounds useful for the synthesis of buprenorphine

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1939920B (zh) * 2005-09-29 2011-08-31 中国人民解放军军事医学科学院毒物药物研究所 东罂粟碱类化合物及其医药用途
ES2329296T3 (es) * 2006-01-05 2009-11-24 Mallinckrodt, Inc. El uso de oripavina como material de partida para buprenorfina.
CA2674915C (en) 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
US20080125592A1 (en) 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
US8546572B2 (en) * 2008-03-31 2013-10-01 Sun Pharmaceutical Industries Limited Process for the preparation of morphinane analogues
ES2462756T3 (es) 2008-09-30 2014-05-26 Mallinckrodt Llc Procedimientos de síntesis de alcaloides opiáceos con formación reducida de impurezas
ES2477190T3 (es) 2008-09-30 2014-07-16 Mallinckrodt Llc Procedimiento de reciclaje para aumentar el rendimiento de una reacción de Grignard en la preparación de derivados alcaloides opiáceos
EP2342207B1 (en) 2008-09-30 2015-11-11 Mallinckrodt LLC Processes for the alkylation of norbuprenorphine with reduced impurity formation
TWI630208B (zh) * 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
CN102462680B (zh) * 2010-11-04 2016-08-03 中国人民解放军军事医学科学院毒物药物研究所 噻吩诺啡的长效缓释微球及其组合物和制备方法
CN102382118A (zh) * 2011-05-23 2012-03-21 浙江仙琚制药股份有限公司 一种7ɑ-乙酰基-6,14-乙基桥四氢蒂巴因的制备方法
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
CN108530452B (zh) * 2017-03-01 2023-02-03 泰州华元医药科技有限公司 高效抗成瘾药物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3433791A (en) * 1960-09-05 1969-03-18 Reckitt & Sons Ltd Endoethano nor oripavines and nor thebaines
US3931189A (en) * 1972-06-21 1976-01-06 Boehringer Ingelheim Gmbh N-(heteroaryl-methyl)-6,14-(endoethano or endoetheno)-7α-hydroxyalkyl-tetrahydro-nororipavines or-northebaines and salts thereof
US5849915A (en) * 1996-05-28 1998-12-15 Dong Kook Pharmaceutical Company, Ltd. Buprenorphine analgesic analogues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925723A (en) * 1960-09-05 1963-05-08 J F Macfarlan & Company Ltd Novel thebaine derivatives

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3433791A (en) * 1960-09-05 1969-03-18 Reckitt & Sons Ltd Endoethano nor oripavines and nor thebaines
US3931189A (en) * 1972-06-21 1976-01-06 Boehringer Ingelheim Gmbh N-(heteroaryl-methyl)-6,14-(endoethano or endoetheno)-7α-hydroxyalkyl-tetrahydro-nororipavines or-northebaines and salts thereof
US5849915A (en) * 1996-05-28 1998-12-15 Dong Kook Pharmaceutical Company, Ltd. Buprenorphine analgesic analogues

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8232397B2 (en) 2008-09-30 2012-07-31 Mallinckrodt Llc Processes for the production of buprenorphine with reduced impurity formation
US8269006B2 (en) 2008-09-30 2012-09-18 Mallinckrodt Llc Processes for the selective amination of ketomorphinans
US8273887B2 (en) 2008-09-30 2012-09-25 Mallinckrodt Llc Processes for synthesis of opiate alkaloid derivatives
EP3023427A1 (en) 2014-11-19 2016-05-25 Siegfried AG Improved method of manufacturing buprenorphine and analogues thereof from oripavine
WO2016078833A1 (en) 2014-11-19 2016-05-26 Siegfried Ag Improved method of manufacturing buprenorphine and analogues thereof from oripavine
EP3067357A1 (en) 2015-03-11 2016-09-14 Siegfried AG Method of manufacturing stereoisomers of buprenorphine and analogues thereof
WO2016142506A1 (en) 2015-03-11 2016-09-15 Siegfried Ag Method of manufacturing stereoisomers of buprenorphine and analogues thereof
US11467076B2 (en) 2016-05-19 2022-10-11 Chapelglade Limited Mattress evaluation system and method
EP4613751A1 (en) 2024-03-07 2025-09-10 Siegfried AG Method of making chemical compounds useful for the synthesis of buprenorphine
WO2025186408A1 (en) 2024-03-07 2025-09-12 Siegfried Ag Method of making chemical compounds useful for the synthesis of buprenorphine

Also Published As

Publication number Publication date
JP2005506985A (ja) 2005-03-10
CN1233645C (zh) 2005-12-28
EP1439179A4 (en) 2005-10-12
ZA200402733B (en) 2005-02-23
ATE390428T1 (de) 2008-04-15
EP1439179B1 (en) 2008-03-26
WO2003024972A8 (en) 2004-06-17
JP4532109B2 (ja) 2010-08-25
MXPA04002422A (es) 2005-04-11
CN1408714A (zh) 2003-04-09
EP1439179A1 (en) 2004-07-21
DE60225827D1 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
WO2003024972A8 (en) New oripavine derivatives and their uses as medicines
HUP0303350A3 (en) Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting pharmaceutical compositions
WO2001027111A3 (de) Bicyclische imidazo-3-yl-aminderivate
WO2005032555A3 (en) Pharmaceutical combinations of hydrocodone and naltrexone
WO2003007802A3 (en) Pharmaceutical combinations of oxycodone and naloxone
AU2001291893A1 (en) Use of substituted imidazo(1,2-a)pyridine-, imidazo(1,2-a)pyrimidine and imidazo(1,2-a)pyrazine-3-yl-amine derivatives for producing NOS-inhibiting medicaments
AP2070A (en) Quinolinone derivatives
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
AU2276100A (en) Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
PL373414A1 (en) 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands
HUT69407A (en) Process for producing quinolin-4-amine-and 1h-imidazo[4,5-c]quinolin-4-amine derivatives as intermediates
GB9914486D0 (en) Medicaments
WO2005011655A3 (en) Pyridazine derivatives and their use as therapeutic agents
WO2005011653A3 (en) Pyridazine derivatives and their use as therapeutic agents
AU2001275798A1 (en) 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
CA2415966A1 (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
WO2000068198A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
WO2002036135A3 (en) Compositions for antitumour treatment containing ecteinascidin 743
CA2460865A1 (en) Quinoline derivatives as neuropeptide y antagonists
GEP20084300B (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
HUP0302433A3 (en) Use of benzophenanthridine alkaloid derivatives as feed additive and for the production of pharmaceutical composition
MY122042A (en) Pro-drugs and counterparts of camptothecin, their application as medicines
WO2000064874A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/002422

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2003528819

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004/02733

Country of ref document: ZA

Ref document number: 200402733

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2002764501

Country of ref document: EP

Ref document number: 00483/KOLNP/2004

Country of ref document: IN

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 13/2003 UNDER (71) THE NAME IN ENGLISH SHOULD READ "INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES PLA, CHINA"

WWP Wipo information: published in national office

Ref document number: 2002764501

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10489656

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2002764501

Country of ref document: EP